Matteo Amicucci, Nurse at Bambino Gesù Children’s Hospital, shared on LinkedIn:
“It was a pleasure to contribute to the Neuroblastoma Educational Day 2026 at Ospedale Pediatrico Bambino Gesù, bringing together healthcare professionals from across Europe to discuss the evolving challenges and opportunities in high-risk and relapsed/refractory neuroblastoma.
I was proud to present our work: ‘Home-Based, Connected Care: Dinutuximab Beta Immunotherapy in Neuroblastoma Beyond Feasibility. Improving Quality of Life and Family Satisfaction’ with Adele Ripà, Italo Ciaralli, Manuela Mampieri, Andrea De Salvo, Angela Mastronuzzi, Angela Di Giannatale, Annalisa Serra and Maria Antonietta De Ioris.
Title: Home-Based, Connected Care: Dinutuximab Beta Immunotherapy in Neuroblastoma Beyond Feasibility. Improving Quality of Life and Family Satisfaction
Authors: Matteo Amicucci, Adele Ripà, Italo Ciaralli, Manuela Mampieri, Andrea De Salvo, Angela Mastronuzzi, Angela Di Giannatale, Annalisa Serra, Maria Antonietta De Ioris
A valuable opportunity to share experiences, discuss innovation in immunotherapy and highlight the essential role of multidisciplinary and nursing care in bringing complex treatments closer to patients and their families.
The Educational Day also marked the beginning of an important week of scientific exchange, culminating in the SIOPEN Research Network 2026 Annual General Meeting.
Thanks also go to our colleagues: Ylenia Ticconi, Eleonora Antenucci, Davide Della Lena, and Matteo Antonucci.
Proud to be part of a community working together to advance care, research and quality of life for children and families affected by neuroblastoma.”
Other articles about neuroblastoma on OncoDaily.
